Navigation Links
BioConvergence®, Contract Manufacturing Organization for the Life Sciences Industry, Announces New Board of Directors
Date:9/19/2013

Bloomington, IN (PRWEB) September 19, 2013

BioConvergence publicly announced today that they have appointed a new Board of Directors. Kathy Jackson was named as Chair, with Dr. Rafik Bishara, Ken Martlage, and Alisa Wright as board members.

Jackson is a senior executive consultant and a principal with Compete Indiana, LLC. She helps growing organizations to identify and correct strategic gaps within their businesses, especially when pertaining to employee care and customer satisfaction. Jackson guides her clients with the best practices and expertise she utilized over the past 12 years in her senior-level executive positions (including President and CEO of Novia CareClinics, LLC) and in her nearly 20 years spent as an educator.

Bishara is a well-known expert in the pharmaceutical supply chain distribution sector. His specialty of Good Cold Chain and Temperature-Controlled Management has led to numerous industry contributions. He has served on the board or as an advisor to many organizations (including Sensitech, Inc., Cryoport, and the World Health Organization); he is also the current Chair of the Pharmaceutical Cold Chain Interest Group (PCCIG) within the Parenteral Drug Association (PDA). He spent 35 years at Eli Lilly & Co. as Director, Quality Knowledge Management, and Technical Support.

Martlage coaches individuals, teams, and corporations in leadership development. He spent 28 years at Eli Lilly & Co. in various management positions and retired in 2000. The past 13 years have been dedicated to international consulting across multiple industries with Compete Indiana, LLC; Phoenix Images, Inc., and Tercon Consulting. His experience includes coaching senior management, team alignment, and facilitating organizational culture shift. Martlage also spent 12 years as a lecturer at Indiana University-Purdue University Indianapolis (IUPUI).

Alisa Wright, CEO of BioConvergence, said of her fe
'/>"/>

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Page: 1 2 3

Related biology technology :

1. HerbalGram Article Details Procedures for Choosing a Contract Analytical Lab for Dietary Ingredients
2. Bio/Pharmaceutical Contract Manufacturing - Industry Analysis of Dose Manufacturing by the Numbers: Composition, Size, Market Shares, Profitability and Outlook
3. Pharma Contract Manufacturing, Research & Packaging Market a New Report Available at ReportsnReports.com
4. Indiana University Contracts with Virtify for Clinical Trial Disclosure Solutions
5. Fortune 500 Company Contracts with Wireless Analytics to Extend Wireless Expense Management & Mobility Management Services Internationally
6. Boehringer Laboratories LLC Awarded HPG Contract for Clinical Suction Regulators
7. PharmSource CMO-CDMO Database Expands Coverage to Include Approved Pharmaceutical Products: Intelligence Resource for Analyzing Bio/Pharmaceutical Contract Manufacturing
8. Clinical Development, Contracts and Outsourcing in MENA & APAC, New Webinar Hosted by Xtalks
9. ChanTest Develops New Cardiotoxicity and Contractility Assay with Human Stem Cell Cardiomyocytes
10. Non-Intrusive Rust Remover Gives Out New Set of Samples to Rust Contractors, My Cleaning Products Says the Spray Cuts $1,000s of Rust Removal Expense
11. BioConvergence® Celebrates Seventh Anniversary as a Life Sciences Contract Service Provider
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/22/2014)... BOSTON , Oct. 22, 2014  Actavis ... specialty pharmaceutical company, and Rhythm, a biopharmaceutical company, today ... to acquire Rhythm,s wholly owned subsidiary, Rhythm Health, Inc., ... for the treatment of diabetic gastroparesis and other GI ... successful Phase 2 trial of relamorelin for the treatment ...
(Date:10/22/2014)... October 22, 2014 WriteResult, LLC ... – has been working with a team of researchers ... Haven Farms Community Farming Collaborative to provide electronic questionnaire ... The study, which started in May, aims to ... provides participants weekly exposure to and participation in urban ...
(Date:10/22/2014)...   Synthetic Biologics, Inc. (NYSE MKT: SYN), ... infections and diseases, announced today that the U.S. Patent ... for a composition of matter patent application that covers ... SYN-004. This is Synthetic Biologics, first allowed patent application ... to the Company,s extensive C. difficile patent ...
(Date:10/20/2014)... The report “Pharmacy Automation Systems Market ... Labeling Systems, Table-top Counters) by End-user (Inpatient Pharmacy ... Trends to 2019” analyzes and studies the major ... Europe, Asia-Pacific, and the Rest of the World ... figures spread through 300 pages and in-depth TOC ...
Breaking Biology Technology:Actavis Signs Option to Acquire Rhythm Subsidiary and its GI Development Product, Relamorelin 2Actavis Signs Option to Acquire Rhythm Subsidiary and its GI Development Product, Relamorelin 3Actavis Signs Option to Acquire Rhythm Subsidiary and its GI Development Product, Relamorelin 4Actavis Signs Option to Acquire Rhythm Subsidiary and its GI Development Product, Relamorelin 5myPROpad™ Topic of Panel Discussion at the Yale Food Systems Symposium 2myPROpad™ Topic of Panel Discussion at the Yale Food Systems Symposium 3Synthetic Biologics Announces Allowance of Key U.S. Composition of Matter Patent for C. difficile Program 2Synthetic Biologics Announces Allowance of Key U.S. Composition of Matter Patent for C. difficile Program 3Synthetic Biologics Announces Allowance of Key U.S. Composition of Matter Patent for C. difficile Program 4Pharmacy Automation Systems Market worth $4,566.2 Million by 2019 - New Research Report by MarketsandMarkets 2Pharmacy Automation Systems Market worth $4,566.2 Million by 2019 - New Research Report by MarketsandMarkets 3Pharmacy Automation Systems Market worth $4,566.2 Million by 2019 - New Research Report by MarketsandMarkets 4
... SALT LAKE CITY, March 17 Axial Biotech, ... of molecular diagnostics,and motion preserving technologies, announced today ... its development of the first genetic,prognostic test for ... million tranche of its Series B financing. The ...
... Declares Preferred Stock Dividend -, SAN DIEGO, Calif., ... ) today announced that its board of directors has,declared ... of common stock,an 8.1% increase over the company,s previous ... equivalent to an annualized dividend,of $1.34 per common share., ...
... IRVINE, Calif., March 14 Masimo Corporation,(Nasdaq: MASI ), ... pulse oximetry, today announced that it is scheduled,to present at ... The Four Seasons Hotel in Las Vegas, NV on Wednesday, ... and CEO, and Mark P. de,Raad, Executive Vice President and ...
Cached Biology Technology:Axial Biotech Meets Major Scientific Milestones; Receives $6 Million Tranche of Series B Financing 2BioMed Realty Trust Announces Increase in Quarterly Common Stock Dividend 2Masimo to Present at Citi Investment Research 5th Annual Small & Mid-Cap Conference 2
(Date:10/19/2014)... in India over the last 30 years contributed ... growth during that time, according to a new ... Change ., "Energy access is fundamental to development: ... including education, communication, and health," says IIASA researcher ... increased energy access is widely agreed to be ...
(Date:10/17/2014)... German . ... in order to reproduce? And why are there two sexes ... latest issue of the research journal Molecular Human Reproduction ... Ramm from Bielefeld University Bielefeld has compiled this special issue ... a female to copulate with several males in quick succession ...
(Date:10/16/2014)... have a new synthesis of recent research findings to ... in the two states. , The Ecology and ... Washington: A Synthesis of the Relevant Biophysical Science and ... published by the U.S. Forest Service,s Pacific Northwest Research ... managers for a synthesis of the large body of ...
Breaking Biology News(10 mins):Improved electricity access has little impact on climate change 2Sperm wars 2New report synthesizes best available science on management of moist mixed-conifer forests 2
... sea ice in the Arctic has shrunk to its ... 30 years ago, opening up the Northwest Passage ... has been historically impassable. In the mosaic image ... September 2007 by the Advanced Synthetic Aperture Radar (ASAR) ...
... 2007 American Society for Microbiology (ASM) sanofi-aventis U.S. ... M.D., Ph.D., Chief, Laboratory of Malaria and Vector ... Bethesda, Maryland. Supported by an unrestricted grant ... in antimicrobial chemotherapy. Dr. Wellems has had ...
... and volunteers who helped in the clean-up effort after ... of Spain exhibit prolonged respiratory symptoms resulting from their ... to examine the long-term effects of such exposures on ... reported in the second issue for September of the ...
Cached Biology News:Satellites witness lowest Arctic ice coverage in history 2Prolonged respiratory problems for oil spill clean-up volunteers 2Prolonged respiratory problems for oil spill clean-up volunteers 3
... is described by end-users to be "a ... fundamentals of light microscopy and electronic imaging. ... it does not require much space and ... lab environment. The DM-BA300 combines Motic's own ...
... Overhead Drive for individual and parallel agitation ... agitation of DASGIP vessels, featuring range of ... ,Up to 16 overhead drives can be ... Systems fedbatch-pro® and cellferm-pro® for microbiology and ...
... Life Science LAS-3000 imaging system combines ... simplified user interface, providing significantly improved ... of modularities. The system is especially ... perfect standard system for Western blotting ...
Capture faint-light images without losing sensitivity or resolution. With its brand new hardware and interface design, the LAS-1000plus turns sample imaging into a simple process....
Biology Products: